Asset Details
Do you wish to reserve the book?
A Monoclonal Antibody to PACAP for Migraine Prevention
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Monoclonal Antibody to PACAP for Migraine Prevention
Do you wish to request the book?
A Monoclonal Antibody to PACAP for Migraine Prevention
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Monoclonal Antibody to PACAP for Migraine Prevention
2024
Overview
In adults with migraine and previous preventive treatment failures, a single infusion of a monoclonal antibody to pituitary adenylate cyclase–activating polypeptide led to fewer migraine days per month than placebo over the next 4 weeks.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Aged
/ Antibodies, Monoclonal, Humanized - administration & dosage
/ Antibodies, Monoclonal, Humanized - adverse effects
/ COVID-19
/ Female
/ Headache
/ Humans
/ Male
/ Migraine
/ Migraine Disorders - diagnosis
/ Migraine Disorders - drug therapy
/ Migraine Disorders - metabolism
/ Outpatient-Based Clinical Medicine
/ Pain
/ Pituitary adenylate cyclase-activating polypeptide
/ Pituitary Adenylate Cyclase-Activating Polypeptide - antagonists & inhibitors
/ Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism
/ Placebos
